IBDEI23U ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35699,2)
 ;;=^5006467
 ;;^UTILITY(U,$J,358.3,35700,0)
 ;;=J15.9^^134^1729^46
 ;;^UTILITY(U,$J,358.3,35700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35700,1,3,0)
 ;;=3^Bacterial Pneumonia,Unspec
 ;;^UTILITY(U,$J,358.3,35700,1,4,0)
 ;;=4^J15.9
 ;;^UTILITY(U,$J,358.3,35700,2)
 ;;=^5008178
 ;;^UTILITY(U,$J,358.3,35701,0)
 ;;=B97.10^^134^1729^58
 ;;^UTILITY(U,$J,358.3,35701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35701,1,3,0)
 ;;=3^Enterovirus as Cause of Diseases Classified Elsewhere,Unspec
 ;;^UTILITY(U,$J,358.3,35701,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,35701,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,35702,0)
 ;;=J30.0^^134^1729^88
 ;;^UTILITY(U,$J,358.3,35702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35702,1,3,0)
 ;;=3^Vasomotor Rhinitis
 ;;^UTILITY(U,$J,358.3,35702,1,4,0)
 ;;=4^J30.0
 ;;^UTILITY(U,$J,358.3,35702,2)
 ;;=^5008201
 ;;^UTILITY(U,$J,358.3,35703,0)
 ;;=B34.9^^134^1729^89
 ;;^UTILITY(U,$J,358.3,35703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35703,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,35703,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,35703,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,35704,0)
 ;;=J12.9^^134^1729^90
 ;;^UTILITY(U,$J,358.3,35704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35704,1,3,0)
 ;;=3^Viral Pneumonia,Unspec
 ;;^UTILITY(U,$J,358.3,35704,1,4,0)
 ;;=4^J12.9
 ;;^UTILITY(U,$J,358.3,35704,2)
 ;;=^5008169
 ;;^UTILITY(U,$J,358.3,35705,0)
 ;;=J84.114^^134^1730^1
 ;;^UTILITY(U,$J,358.3,35705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35705,1,3,0)
 ;;=3^AC Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,35705,1,4,0)
 ;;=4^J84.114
 ;;^UTILITY(U,$J,358.3,35705,2)
 ;;=^340536
 ;;^UTILITY(U,$J,358.3,35706,0)
 ;;=J84.09^^134^1730^2
 ;;^UTILITY(U,$J,358.3,35706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35706,1,3,0)
 ;;=3^Alveolar/Parieto-Alveolar Conditions NEC
 ;;^UTILITY(U,$J,358.3,35706,1,4,0)
 ;;=4^J84.09
 ;;^UTILITY(U,$J,358.3,35706,2)
 ;;=^5008299
 ;;^UTILITY(U,$J,358.3,35707,0)
 ;;=J67.2^^134^1730^3
 ;;^UTILITY(U,$J,358.3,35707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35707,1,3,0)
 ;;=3^Bird Fancier's Lung
 ;;^UTILITY(U,$J,358.3,35707,1,4,0)
 ;;=4^J67.2
 ;;^UTILITY(U,$J,358.3,35707,2)
 ;;=^14840
 ;;^UTILITY(U,$J,358.3,35708,0)
 ;;=J68.4^^134^1730^5
 ;;^UTILITY(U,$J,358.3,35708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35708,1,3,0)
 ;;=3^Chr Resp Cond d/t Chemicals/Gases/Fumes/Vapors
 ;;^UTILITY(U,$J,358.3,35708,1,4,0)
 ;;=4^J68.4
 ;;^UTILITY(U,$J,358.3,35708,2)
 ;;=^5008285
 ;;^UTILITY(U,$J,358.3,35709,0)
 ;;=M34.1^^134^1730^4
 ;;^UTILITY(U,$J,358.3,35709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35709,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,35709,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,35709,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,35710,0)
 ;;=J84.116^^134^1730^6
 ;;^UTILITY(U,$J,358.3,35710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35710,1,3,0)
 ;;=3^Cryptogenic Organizing Pneumonia
 ;;^UTILITY(U,$J,358.3,35710,1,4,0)
 ;;=4^J84.116
 ;;^UTILITY(U,$J,358.3,35710,2)
 ;;=^340539
 ;;^UTILITY(U,$J,358.3,35711,0)
 ;;=J84.117^^134^1730^7
 ;;^UTILITY(U,$J,358.3,35711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35711,1,3,0)
 ;;=3^Desquamative Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,35711,1,4,0)
 ;;=4^J84.117
 ;;^UTILITY(U,$J,358.3,35711,2)
 ;;=^340540
 ;;^UTILITY(U,$J,358.3,35712,0)
 ;;=M32.0^^134^1730^8
 ;;^UTILITY(U,$J,358.3,35712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35712,1,3,0)
 ;;=3^Drug-Induced Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,35712,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,35712,2)
 ;;=^5011752
